AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2016
Jan 6, 2016
30718_dirs_2016-01-06_698cd525-2198-41c2-98ca-4182a5577bfa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-01-01
Reporting Person: Gould Kevin S (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2500.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $97.23 | 2022-07-09 | Common Stock (50000.00) | Direct | |
| Stock Options (Right to buy) | $97.23 | 2022-07-09 | Common Stock (15000.00) | Direct |
Footnotes
F1: Represents 2,500 restricted stock units that vest in increments of 833 shares on 07/09/16 and 07/09/17 and 834 shares on 07/09/18.
F2: 50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
F3: Vests as to 3,750 shares on each of 07/09/16, 07/09/17, 07/09/18 and 07/09/19
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4